Antiretroviral simplification with darunavir/ritonavir monotherapy in routine clinical practice: safety, effectiveness, and impact on lipid profile.

by José R Santos, José Moltó, Josep M Llibre, Eugenia Negredo, Isabel Bravo, Arelly Ornelas, Bonaventura Clotet, Roger Paredes
Published 2012-01-01

Effectiveness of a Treatment Switch to Nevirapine plus Tenofovir and Emtricitabine (or Lamivudine) in Adults with HIV-1 Suppressed Viremia.

by Josep M Llibre, Isabel Bravo, Arelly Ornelas, José R Santos, Jordi Puig, Raquel Martin-Iguacel, Roger Paredes, Bonaventura Clotet
Published 2015-01-01

Correction: An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial T...

by Josep M Llibre, François Raffi, Graeme Moyle, Georg Behrens, Stephane Bouee, Geraldine Reilly, Peter Borg, David Piontkowsky, Felipe Rogatto
Published 2016-01-01

An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy.

by Josep M Llibre, François Raffi, Graeme Moyle, Georg Behrens, Stephane Bouee, Geraldine Reilly, Peter Borg, David Piontkowsky, Felipe Rogatto
Published 2016-01-01

EPICE-HIV: An Epidemiologic Cost-Effectiveness Model for HIV Treatment.

by Björn Vandewalle, Josep M Llibre, Jean-Jacques Parienti, Andrew Ustianowski, Ricardo Camacho, Colette Smith, Alec Miners, Diana Ferreira, Jorge Félix
Published 2016-01-01

Virological efficacy in cerebrospinal fluid and neurocognitive status in patients with long-term monotherapy based on lopinavir/ritonavir: an exploratory study.

by José R Santos, José A Muñoz-Moreno, José Moltó, Anna Prats, Adrià Curran, Pere Domingo, Josep M Llibre, Daniel R McClernon, Isabel Bravo, Jaume Canet, Victoria Watson, David Back, Bonaventura Clotet
Published 2013-01-01

Deep molecular characterization of HIV-1 dynamics under suppressive HAART.

by Maria J Buzón, Francisco M Codoñer, Simon D W Frost, Christian Pou, Maria C Puertas, Marta Massanella, Judith Dalmau, Josep M Llibre, Mario Stevenson, Julià Blanco, Bonaventura Clotet, Roger Paredes, Javier Martinez-Picado
Published 2011-10-01

Different plasma markers of inflammation are influenced by immune recovery and cART composition or intensification in treated HIV infected individuals.

by Marta Massanella, Dan Ouchi, Silvia Marfil, Josep M Llibre, Maria C Puertas, María J Buzón, Douglas D Richman, Elisa Orna, Mario Stevenson, Josep M Gatell, Pere Domingo, Eugènia Negredo, Javier Martinez-Picado, Bonaventura Clotet, Julià Blanco
Published 2014-01-01

Effect of maraviroc intensification on HIV-1-specific T cell immunity in recently HIV-1-infected individuals.

by Ai Kawana-Tachikawa, Josep M Llibre, Isabel Bravo, Roser Escrig, Beatriz Mothe, Jordi Puig, Maria C Puertas, Javier Martinez-Picado, Julia Blanco, Christian Manzardo, Jose M Miro, Aikichi Iwamoto, Anton L Pozniak, Jose M Gatell, Bonaventura Clotet, Christian Brander, MARAVIBOOST Investigators
Published 2014-01-01

Strategies to reengage patients lost to follow up in HIV care in high income countries, a scoping review

by Jorge Palacio-Vieira, Juliana Maria Reyes-Urueña, Arkaitz Imaz, Andreu Bruguera, Luis Force, Amat Orti Llaveria, Josep M. Llibre, Ingrid Vilaró, Francesc Homar Borràs, Vicenç Falcó, Melchor Riera, Pere Domingo, Elisa de Lazzari, Josep M. Miró, Jordi Casabona, PICIS study group
Published 2021-08-01

Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortium.

by Bastian Neesgaard, Amanda Mocroft, Robert Zangerle, Ferdinand Wit, Fiona Lampe, Huldrych F Günthard, Coca Necsoi, Matthew Law, Cristina Mussini, Antonella Castagna, Antonella d'Arminio Monforte, Christian Pradier, Nikoloz Chkhartisvilli, Juliana Reyes-Uruena, Jörg Janne Vehreschild, Jan-Christian Wasmuth, Anders Sönnerborg, Christoph Stephan, Lauren Greenberg, Josep M Llibre, Alain Volny-Anne, Lars Peters, Annegret Pelchen-Matthews, Vani Vannappagari, Joel Gallant, Armin Rieger, Mike Youle, Dominique Braun, Stephane De Wit, Kathy Petoumenos, Vanni Borghi, Vincenzo Spagnuolo, Tengiz Tsertsvadze, Jens Lundgren, Lene Ryom, RESPOND study group
Published 2020-01-01